Various TLR agonists are currently under investigation in clinical trials for their ability to orchestrate antitumor immunity. The antitumor responses are largely attributed to their aptitude to stimulate APCs such as DCs which in turn, activate tumor-specific T cell responses. However, there is a p...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!